Topics
CNS Tumors | Treatment | Clinical trials | Fadraciclib
Home > Publications > Topics > CNS Tumors > Treatment > Clinical trials > Fadraciclib
Rubio-San-Simón A, Marshall LV, Karamouza E, André
N, Abbou S, Rubino J, Nebchi S, Aerts I, Thebaud E, Brisset C,
Ducassou S, Le Teuff G, Geoerger B.
Phase
I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with
Chemotherapy in Children with Advanced Malignancies: Arm K of the
AcSé-ESMART Trial.
Target
Oncol. 2026 Mar 16;21(2):199-211. doi:
10.1007/s11523-026-01208-1. PMID:
41838385. ClinicalTrials.gov.
ˍ